Clinical Factors Associated with Hepatocellular Iron Deposition in End-stage Liver Disease
Open Access
- 8 July 2020
- journal article
- research article
- Published by Xia & He Publishing in Journal of Clinical and Translational Hepatology
- Vol. 8 (3), 1-9
- https://doi.org/10.14218/jcth.2020.00022
Abstract
Background and Aims: Hepatocellular iron accumulation in patients with chronic liver disease has been linked to adverse outcomes. The objective of this study was to identify clinical factors associated with hemosiderosis.Keywords
This publication has 43 references indexed in Scilit:
- Altered expression of iron regulatory genes in cirrhotic human livers: clues to the cause of hemosiderosis?Laboratory Investigation, 2008
- HFE C282Y mutations are associated with advanced hepatic fibrosis in Caucasians with nonalcoholic steatohepatitisJournal of Hepatology, 2007
- Influence of clinical factors on the haemolysis marker haptoglobinEuropean Journal of Clinical Investigation, 2006
- Hemosiderosis is associated with accelerated decompensation and decreased survival in patients with cirrhosisLiver International, 2005
- The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammationJCI Insight, 2002
- HFE mutations, hepatic iron, and fibrosis: Ethnic-specific association of NASH with C282Y but not with fibrotic severityJournal of Hepatology, 2002
- Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitisJournal of Hepatology, 1999
- Hepatic iron overload in patients with chronic viral hepatitis: Role of HFE gene mutationsJournal of Hepatology, 1998
- Hereditary hemochromatosisClinica Chimica Acta; International Journal of Clinical Chemistry, 1996
- THE ANEMIA OF LIVER DISEASE: OBSERVATIONS ON ITS MECHANISM 1JCI Insight, 1955